ACCOUNTS - Final Accounts


Caseware UK (AP4) 2020.0.247 2020.0.247 2021-03-312021-03-31The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.12020-04-01falseconsultancy in the health care industry1truetrue 06159308 2020-04-01 2021-03-31 06159308 2019-04-01 2020-03-31 06159308 2021-03-31 06159308 2020-03-31 06159308 c:Director1 2020-04-01 2021-03-31 06159308 d:FurnitureFittings 2020-04-01 2021-03-31 06159308 d:FurnitureFittings 2021-03-31 06159308 d:FurnitureFittings 2020-03-31 06159308 d:FurnitureFittings d:OwnedOrFreeholdAssets 2020-04-01 2021-03-31 06159308 d:Goodwill 2021-03-31 06159308 d:Goodwill 2020-03-31 06159308 d:CurrentFinancialInstruments 2021-03-31 06159308 d:CurrentFinancialInstruments 2020-03-31 06159308 d:CurrentFinancialInstruments d:WithinOneYear 2021-03-31 06159308 d:CurrentFinancialInstruments d:WithinOneYear 2020-03-31 06159308 d:ShareCapital 2021-03-31 06159308 d:ShareCapital 2020-03-31 06159308 d:RetainedEarningsAccumulatedLosses 2021-03-31 06159308 d:RetainedEarningsAccumulatedLosses 2020-03-31 06159308 d:FinancialAssetsDesignatedFairValueThroughProfitOrLoss 2021-03-31 06159308 d:FinancialAssetsDesignatedFairValueThroughProfitOrLoss 2020-03-31 06159308 c:FRS102 2020-04-01 2021-03-31 06159308 c:AuditExempt-NoAccountantsReport 2020-04-01 2021-03-31 06159308 c:FullAccounts 2020-04-01 2021-03-31 06159308 c:PrivateLimitedCompanyLtd 2020-04-01 2021-03-31 06159308 2 2020-04-01 2021-03-31 iso4217:GBP xbrli:pure

Registered number: 06159308









SYNAPSIS HEALTHCARE CONSULTING LIMITED







UNAUDITED

FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MARCH 2021

 
SYNAPSIS HEALTHCARE CONSULTING LIMITED
REGISTERED NUMBER: 06159308

BALANCE SHEET
AS AT 31 MARCH 2021

2021
2020
Note
£
£

Fixed assets
  

Tangible assets
 5 
12,171
14,319

  
12,171
14,319

Current assets
  

Debtors: amounts falling due within one year
 6 
2,760
50,070

Cash at bank and in hand
 7 
496,012
413,114

  
498,772
463,184

Creditors: amounts falling due within one year
 8 
(71,840)
(29,767)

Net current assets
  
 
 
426,932
 
 
433,417

Total assets less current liabilities
  
439,103
447,736

  

Net assets
  
439,103
447,736


Capital and reserves
  

Called up share capital 
  
10
10

Profit and loss account
  
439,093
447,726

  
439,103
447,736


Page 1

 
SYNAPSIS HEALTHCARE CONSULTING LIMITED
REGISTERED NUMBER: 06159308
    
BALANCE SHEET (CONTINUED)
AS AT 31 MARCH 2021

The director considers that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The director acknowledges her responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the statement of income and retained earnings in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf on 21 July 2021.





................................................
Susan Howson
Director


The notes on pages 3 to 7 form part of these financial statements.

Page 2

 
SYNAPSIS HEALTHCARE CONSULTING LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2021

1.


General information

Synapsis Healthcare Consulting Limited is a private company limited by shares, incorporated in England.   The principal activity of the Company is that of consultancy in the health care industry.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with Section 1A of Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland and the Companies Act 2006.

The following principal accounting policies have been applied:

 
2.2

Revenue

Turnover is recognised to the extent that it is probable that the economic benefits will flow to the Company and the turnover can be reliably measured. Turnover is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. The following criteria must also be met before turnover is recognised:

Rendering of services

Turnover from a contract to provide services is recognised in the period in which the services are provided in accordance with the stage of completion of the contract when all of the following conditions are satisfied:
the amount of turnover can be measured reliably;
it is probable that the Company will receive the consideration due under the contract;
the stage of completion of the contract at the end of the reporting period can be measured reliably; and
the costs incurred and the costs to complete the contract can be measured reliably.

 
2.3

Government grants

Grants are accounted under the accruals model as permitted by FRS 102. Grants relating to expenditure on tangible fixed assets are credited to profit or loss at the same rate as the depreciation on the assets to which the grant relates. The deferred element of grants is included in creditors as deferred income.
Grants of a revenue nature are recognised in the Statement of income and retained earnings in the same period as the related expenditure.

 
2.4

Interest income

Interest income is recognised in profit or loss using the effective interest method.

Page 3

 
SYNAPSIS HEALTHCARE CONSULTING LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2021

2.Accounting policies (continued)

 
2.5

Taxation

Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the balance sheet date in the countries where the Company operates and generates income.

 
2.6

Intangible assets

Intangible assets are initially recognised at cost. After recognition, under the cost model, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

All intangible assets are considered to have a finite useful life. If a reliable estimate of the useful life cannot be made, the useful life shall not exceed ten years.

 
2.7

Tangible fixed assets

Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, on a reducing balance basis.

Depreciation is provided on the following basis:

Fixtures and fittings
-
15% reducing balance

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in profit or loss.

 
2.8

Debtors

Short term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

 
2.9

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

Page 4

 
SYNAPSIS HEALTHCARE CONSULTING LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2021

2.Accounting policies (continued)

 
2.10

Creditors

Short term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

 
2.11

Financial instruments

The Company only enters into basic financial instrument transactions that result in the recognition of financial assets and liabilities like trade and other debtors and creditors, loans from banks and other third parties, loans to related parties and investments in ordinary shares.

 
2.12

Dividends

Equity dividends are recognised when they become legally payable. Interim equity dividends are recognised when paid. Final equity dividends are recognised when approved by the shareholders at an annual general meeting.


3.


Employees

The average monthly number of employees, including directors, during the year was 1 (2020 - 1).


4.


Intangible assets




Goodwill

£



Cost


At 1 April 2020
15,000



At 31 March 2021

15,000



Amortisation


At 1 April 2020
15,000



At 31 March 2021

15,000



Net book value



At 31 March 2021
-



At 31 March 2020
-



Page 5

 
SYNAPSIS HEALTHCARE CONSULTING LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2021

5.


Tangible fixed assets





Fixtures and fittings

£



Cost or valuation


At 1 April 2020
20,066



At 31 March 2021

20,066



Depreciation


At 1 April 2020
5,747


Charge for the year on owned assets
2,148



At 31 March 2021

7,895



Net book value



At 31 March 2021
12,171



At 31 March 2020
14,319


6.


Debtors

2021
2020
£
£


Trade debtors
2,760
50,070

2,760
50,070



7.


Cash and cash equivalents

2021
2020
£
£

Cash at bank and in hand
496,012
413,114

496,012
413,114


Page 6

 
SYNAPSIS HEALTHCARE CONSULTING LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2021

8.


Creditors: Amounts falling due within one year

2021
2020
£
£

Corporation tax
8,150
4,136

Other taxation and social security
2,099
7,289

Other creditors
60,466
17,217

Accruals and deferred income
1,125
1,125

71,840
29,767



9.


Financial instruments

2021
2020
£
£

Financial assets


Financial assets measured at fair value through profit or loss
496,012
413,114




Financial assets measured at fair value through profit or loss comprise of cash at bank and in hand.


10.


Controlling party

The Company is controlled by the director, Susan Howson, by virtue of her shareholding as described in the director's report.

 
Page 7